Lanabecestat(AZD3293,LY-3314814)
Cat. No.: DC9946
Chemical Structure
1383982-64-6
We are official vendor of:
More than 5000 active chemicals with high quality for research!
Field of application
AZD3293 is a potent and selective orally active, brain-permeable BACE1 inhibitor,currently in development as a potential treatment for early Alzheimer’s disease.
| Cas No.: |
1383982-64-6 |
| Chemical Name: |
(1,4-trans,1'R)-4-methoxy-5''-methyl-6'-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine |
| Synonyms: |
AZD 3293,LY3314814,AZD-3293,LY 3314814 |
| SMILES: |
CC#CC1=CC(C2=CC([C@@]34N=C(C)C(N)=N4)=C(C[C@@]53CC[C@@H](OC)CC5)C=C2)=CN=C1 |
| Formula: |
C26H28N4O |
| M.Wt: |
412.53 |
| Purity: |
>98% |
| Sotrage: |
4°C for 1 year, -20°C for more than 2 years |
| Description: |
AZD3293 is an, orally administered, inhibitor of BACE1, the β-secretase sheddase that cleaves the APP protein to release APP's C99 fragment. This fragment then becomes a substrate for subsequent γ-secretase cleavage and Aβ peptide generation. The rationale is that inhibiting BACE1 will reduce amyloid-related toxicity in Alzheimer's disease. AZD3293 is one of several BACE1/2 inhibitors currently in development. |
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
Get Quote
